NORIMUN AS
Closed at January 8th, 2025, Voluntary liquidation
Å utvikle ingredienser, produkter, teknologi og tjenester knyttet til
IgY tilknyttet funksjonell ernæring og passiv immunisering, innen
markeder for akva- og husdyrproduksjon samt human ernæring,
helseprodukter, legemidler og det som naturlig inn under dette.
Produksjon og salg av farmasøytiske råvarer. Forskning og utvikling
innen bioteknologi.
Keywords
researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors
Organization
- Chairman of the board
- PO
- Operation time
- 11 years
- - Oct 1, 2014 to Jan 8, 2025
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 1,244,253
- 1 share class
- Total number of shareholders
- 3
- companies
- Belongs to group of
Financials
- Total operating income 2023
- 1,062,170
- NOK
- Annual total result 2023
- -1,202,962
- NOK
- Total equity 2023
- 1,057,952
- NOK
Last update: Dec 31, 2024
Management
Board
| Name | Role | Shares |
|---|---|---|
PO | Chairman | 11.91 % indirectly |
JA | Board Member | - |
JO | Board Member | 11.91 % indirectly |
ØE 1959 | Board Member | 2.98 % indirectly |
RG | Board Member | 5.96 % indirectly |
KL 1968 | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
JO | Board Member | 11.91 % indirectly |
PO | Chairman | 11.91 % indirectly |
RG | Board Member | 5.96 % indirectly |
ØE 1959 | Board Member | 2.98 % indirectly |
HI 1962 | - | 2.98 % indirectly |
Last update: Oct 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 799,552 | 64.26 % | |
| Ordinary shares | 296,468 | 23.83 % | |
| Ordinary shares | 148,233 | 11.91 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 14,799,766,000Operating profit 2024: NOK 146,376,000Employees: 2806
Financials
in NOK
Summary
| Year | 2023 | 2022 | 2021 |
|---|---|---|---|
Total operating income | 1,062,170 | 227,000 | 316,832 |
Annual Total Result | -1,202,962 | -8,306,009 | -4,231,880 |
Total assets | 1,407,249 | 5,262,141 | 12,537,279 |
Total liabilities | 349,297 | 3,001,227 | 13,200,516 |
Total equity | 1,057,952 | 2,260,914 | -663,237 |
P&L
| Year | 2023 | 2022 | 2021 |
|---|---|---|---|
Total operating income | 1,062,170 | 227,000 | 316,832 |
Total operating costs | 2,190,886 | 8,485,936 | 2,099,188 |
Operating result | -1,128,716 | -8,258,936 | -1,782,356 |
Financial income/costs | -74,246 | -47,073 | -2,449,525 |
Profit before tax | -1,202,962 | -8,306,009 | -4,231,880 |
Total tax & extraordinary income/cost | 0 | 0 | 0 |
Annual Total Result | -1,202,962 | -8,306,009 | -4,231,880 |
Balance overview
| Year | 2023 | 2022 | 2021 |
|---|---|---|---|
Total fixed assets | 52,441 | 513,649 | 6,869,362 |
Total current assets | 1,354,808 | 4,748,492 | 5,667,917 |
Total assets | 1,407,249 | 5,262,141 | 12,537,279 |
Short term debt | 349,297 | 3,001,227 | 1,200,516 |
Long term debt | 0 | 0 | 12,000,000 |
Total liabilities | 349,297 | 3,001,227 | 13,200,516 |
Contributed capital | 1,244,253 | 15,121,456 | 3,769,334 |
Retained earnings | -186,301 | -12,860,542 | -4,432,571 |
Total equity | 1,057,952 | 2,260,914 | -663,237 |
Total equity and liabilities | 1,407,249 | 5,262,141 | 12,537,279 |
Classification
21st company classification
BETA
Industrial daughter company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology